Cargando…
The Potential Mechanism of Wuwei Qingzhuo San against Hyperlipidemia Based on TCM Network Pharmacology and Validation Experiments in Hyperlipidemia Hamster
Wuwei Qingzuo San (WWQZS), as a renowned traditional Mongolian patent medicine approved by Chinese State Food and Drug Administration, is used to treat hyperlipidemia, indigestion, and other ailments related to disorder of production of essence and phlegm, a typical abnormal metabolism of blood in t...
Autores principales: | Li, Jianliang, Wang, Chaolu, Song, Lin, Cai, Shuzhen, Li, Zhiyong, Tu, Ya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7212318/ https://www.ncbi.nlm.nih.gov/pubmed/32454862 http://dx.doi.org/10.1155/2020/5369025 |
Ejemplares similares
-
Wuwei Qingzhuo San Ameliorates Hyperlipidemia in Mice Fed With HFD by Regulating Metabolomics and Intestinal Flora Composition
por: Ge, Shasha, et al.
Publicado: (2022) -
Anthelmintics nitazoxanide protects against experimental hyperlipidemia and hepatic steatosis in hamsters and mice
por: Li, Fengfeng, et al.
Publicado: (2022) -
Hypolipidemic Effect of Tomato Juice in Hamsters in High Cholesterol Diet-Induced Hyperlipidemia
por: Lee, Li-Chen, et al.
Publicado: (2015) -
Hypolipidemic effect of XH601 on hamsters of Hyperlipidemia and its potential mechanism
por: Zhao, Meng-Jie, et al.
Publicado: (2017) -
Pharmacological treatment of hypertension and hyperlipidemia in Izhevsk, Russia
por: Cybulsky, Marta, et al.
Publicado: (2016)